Trajenta 5mg
| SKU | 1413 |
|---|---|
| Generic For | Tradjenta |
| Strength | 5mg |
| Manufacturer | Boehringer Ingelheim, Brazil |
| Active Ingredient | Linagliptin |
Out Of Stock
Trajenta 5mg (Linagliptin) – Affordable Tradjenta Alternative
Type 2 diabetes is a progressive disorder that occurs with increasing prevalence in the elderly and those with one or more additional disease. Diabetes control becomes more challenging with these co-existing problems. To gain control over blood glucose levels, many people with diabetes require more than one diabetes medication and additional medications. As a result, the development of new diabetes medication that can help meet this challenge has been a topic of research. The DPP4 inhibitors are one of the recently approved categories of oral diabetic drugs for the treatment of hyperglycemia in adults.
Trajenta 5mg, a DPP4 inhibitor drug, is an approved oral antidiabetic drug that has been developed to control hyperglycemia effectively. It is formulated with Linagliptin, which work by regulating the levels of insulin hormone that your body produces after eating. The medicine taken along with diet and exercise may help lower blood sugar levels. It is a once-daily addition to your treatment regimen that your health care specialist might recommend. In multiple clinical trials, the drug has been shown to be effective in adults with Type 2 diabetes and have a good safety profile.
The usage instructions of Trajenta 5 mg
The usual dose of Trajenta is 5 mg once a day. Make sure you start the treatment only after consultation of health care specialist because there are many factors can affect the dose of medication that an individual requires. These factors include body weight, current patient's condition, other medical conditions, and medications. If your healthcare specialist has prescribed a different dose from the one listed on this document, do not change your dose or the dosing schedule without consulting your health care specialist. Trajenta 5 mg tablet can be taken before or after consuming food. Make sure you take this antidiabetic medicine exactly as prescribed by your health care specialist. Try not to miss the dose and continue with your regular dosing schedule to achieve blood sugar control. Store the medicine at room temperature and keep the tablets away from your children and pets.
What are the side effects Trajenta 5 mg?
Users may experience side effects of Trajenta. These may include inflammation of the pancreas, which may be severe. Before you start the treatment with Linagliptin, inform your health care specialist if you have a history of gallstones, pancreatitis, or high triglyceride levels.
Stop taking Trajenta, and visit your health care specialist if you have experienced severe pain in the abdomen that does not go away. The abdominal pain may radiate through your abdomen to back. The severe pain may develop with or with nausea. This may be a symptom of pancreatitis.
Tell your health care specialist if you ever had heart failure or have kidney impairment.
What are the uses of Trajenta 5 mg?
Your doctor may have suggested Trajenta 5 mg medicine along with diet and exercise to decrease blood glucose levels in patients with Type 2 diabetes. The medicine is prescribed alone, or in combination with another antidiabetic medicine if the medicine alone is not sufficient to control your sugar levels. Patients are advised to continue to follow the diet and regular exercise recommended by the doctor during the treatment plan. The medicine is not for people with Type 1 diabetes.
The mode of action of Trajenta 5 mg
Trajenta is made up of the active ingredient Linagliptin, DPP4 inhibitors, which is believed to improve the levels of insulin hormone after a meal and lower the amount of sugar made by the body. The decrease in the blood sugar levels may help to prevent or delay complications associated with diabetes, such as blindness, kidney disease, heart disease, foot amputation.
What is Linagliptin and what condition does it treat?
Linagliptin is an oral antidiabetic medication marketed under the brand name Trajenta 5mg, used to treat type 2 diabetes mellitus in adults. This DPP-4 inhibitor helps control blood sugar levels when combined with diet and exercise. Unlike insulin injections, Linagliptin comes in tablet form and works by regulating glucose naturally produced by your body. It's particularly beneficial for patients whose diabetes isn't adequately controlled through lifestyle changes alone. The medication belongs to a class called dipeptidyl peptidase-4 inhibitors, which support pancreatic function and improve glycemic control throughout the day.
How does Linagliptin work in the body?
Linagliptin works by blocking the DPP-4 enzyme, which naturally breaks down incretin hormones in your digestive system. By inhibiting this enzyme, Trajenta 5mg allows incretins to remain active longer, stimulating insulin release when blood glucose rises after meals. This diabetes medication simultaneously reduces the amount of sugar your liver produces. Unlike some glucose-lowering drugs, this DPP-4 inhibitor works in a glucose-dependent manner, meaning it primarily acts when blood sugar is elevated, reducing hypoglycemia risk. The result is better glycemic control throughout the day without forcing your pancreas to overproduce insulin constantly.
How long does Trajenta 5mg take to work?
Trajenta 5mg begins working within hours of your first dose, with Linagliptin reaching peak blood concentration approximately 90 minutes after administration. However, noticeable improvements in blood sugar control typically emerge after one to two weeks of consistent daily use. Full therapeutic benefits of this antidiabetic medication usually develop within three months as your body adjusts to the DPP-4 inhibitor. Your healthcare provider will monitor your HbA1c levels to assess long-term glucose management. Individual response times vary based on diabetes severity, diet adherence, and whether you're taking Trajenta alone or with other glucose-lowering medications.
When and how should I take Trajenta 5mg?
Take Trajenta 5mg once daily at the same time each day, with or without food, as directed by your doctor. Swallow the tablet whole with water—don't crush, chew, or split it. Many patients find morning dosing easiest to remember, though any consistent time works for this DPP-4 inhibitor. If you miss a dose of Linagliptin, take it as soon as you remember unless it's nearly time for your next scheduled dose. Never double up to compensate for forgotten tablets. Consistent timing helps maintain stable blood glucose levels throughout the day and maximizes this diabetes medication's effectiveness.
Is Trajenta 5mg safe for long-term use?
Trajenta 5mg is designed for long-term daily use in managing type 2 diabetes, with clinical studies demonstrating safety profiles extending several years. Linagliptin has shown consistent efficacy and tolerability when used continuously as part of a diabetes management plan. This DPP-4 inhibitor doesn't typically lose effectiveness over time, unlike some glucose-lowering medications. Long-term users should attend regular check-ups to monitor kidney function, HbA1c levels, and overall diabetes control. The medication's favorable safety record and once-daily convenience make it suitable for ongoing glycemic management when lifestyle modifications and other antidiabetic approaches are combined appropriately.
Can I take Trajenta 5mg with other medicines?
Trajenta 5mg is frequently prescribed alongside other diabetes medications including metformin, sulfonylureas, or insulin to enhance blood sugar control. Linagliptin has relatively few drug interactions compared to some antidiabetic medications, making combination therapy generally safe. However, inform your healthcare provider about all medications, supplements, and herbal products you're using, as some combinations may require dosage adjustments. Drugs affecting kidney function warrant particular attention since this DPP-4 inhibitor is eliminated through renal pathways. Blood pressure medications, cholesterol drugs, and most common prescriptions typically don't conflict with this glucose-lowering medication when properly monitored.
How does Trajenta 5mg compare to similar medicines in its class?
Trajenta 5mg belongs to the DPP-4 inhibitor class alongside medications like sitagliptin and saxagliptin, all offering comparable blood sugar reduction. Linagliptin distinguishes itself with primarily non-renal elimination, making it advantageous for patients with kidney concerns who might need dosage adjustments with other diabetes medications. This antidiabetic drug maintains consistent 5mg dosing regardless of renal function in most cases. Clinical trials show similar HbA1c reductions across DPP-4 inhibitors, though individual tolerance varies. The once-daily convenience and low hypoglycemia risk are common benefits throughout this glucose-lowering medication category, with specific choice often depending on patient-specific factors and prescriber familiarity.
Is generic Linagliptin as effective as branded Trajenta?
Generic Linagliptin contains the identical active ingredient as branded Trajenta 5mg and delivers equivalent therapeutic effectiveness for type 2 diabetes management. Regulatory authorities require generic diabetes medications to demonstrate bioequivalence, meaning they work the same way in your body as brand-name versions. The DPP-4 inhibitor molecule itself is identical whether branded or generic. Cost differences exist because generic manufacturers don't bear original research expenses, making this antidiabetic medication more affordable without sacrificing quality. Both versions must meet strict manufacturing standards. Your blood sugar control should remain consistent whether using generic Linagliptin or branded Trajenta, assuming proper dosing and adherence.
Why do patients choose PremiumRxDrugs for Trajenta 5mg?
Patients consistently select PremiumRxDrugs for Trajenta 5mg because we combine affordability with authenticity for diabetes medications. Our competitive pricing makes this DPP-4 inhibitor more accessible without compromising quality—every Linagliptin tablet is manufacturer-sourced and genuine. Managing type 2 diabetes requires ongoing medication, so our convenient reorder system and prescription management tools simplify refills. Discreet worldwide shipping with free delivery options ensures privacy and value. Having served customers across USA, UK, Australia, Canada, and globally for over ten years, we've built trust through consistent reliability. Whether you need branded Trajenta or generic alternatives, our licensed pharmacy status guarantees safe, legitimate antidiabetic medication access.
What are the common side effects of Linagliptin?
Common side effects of Linagliptin include stuffy or runny nose, sore throat, and cold-like symptoms affecting the upper respiratory tract. Some patients experience joint pain or muscle discomfort when taking this DPP-4 inhibitor. Headaches occur occasionally during initial diabetes medication adjustment periods. Unlike some antidiabetic drugs, hypoglycemia is uncommon with Linagliptin alone but may increase when combined with insulin or sulfonylureas. Most side effects are mild and temporary as your body adapts to the glucose-lowering medication. Serious reactions like pancreatitis or severe joint pain are rare but require immediate medical attention. Many patients tolerate this diabetes treatment well with minimal adverse effects.
Who should avoid taking Linagliptin?
Individuals with known hypersensitivity or allergic reactions to Linagliptin or DPP-4 inhibitors should avoid this diabetes medication entirely. This antidiabetic drug is not appropriate for type 1 diabetes or diabetic ketoacidosis treatment. Patients with a history of pancreatitis should discuss risks carefully with healthcare providers before starting this glucose-lowering medication. Pregnant or breastfeeding women require alternative diabetes management approaches since safety data for Linagliptin in these situations remains limited. Children under 18 typically aren't prescribed this medication as studies focus on adult populations. Anyone with severe kidney disease should undergo careful evaluation, though Linagliptin generally requires no renal dosing adjustments unlike some diabetes medications.
Login
Sign Up
Login
Sign Up